Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03855800 · ClinicalTrials.gov registry record · NA
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
A NA study of Pancreas Cyst, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 1
- Study location
NCT03855800: Recruiting NA study of Pancreas Cyst, sponsored by Mayo Clinic.
NCT03855800 is a NA study of Pancreas Cyst that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 800 participants, below the 7,094-participant average among 3 other Pancreas Cyst trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03855800, a NA study of Pancreas Cyst, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
Primary Outcome
Number of biospecimens collected
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Blood, stool, pancreatic juice and cyst fluid collection
- PROCEDURE Pancreatic Surgery
- PROCEDURE Endoscopy Exam
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2030-12-30 |
| Phase | NA |
What NCT03855800 shows while recruiting
NCT03855800 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 7,094-participant average among 3 other Pancreas Cyst trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Pancreas Cyst appearing as the primary indexed condition, and to 3 interventions - of which Blood, stool, pancreatic juice and cyst fluid collection is the first listed.
NCT03855800 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03855800 about?
NCT03855800 is a clinical study titled "Molecular Detection of Advanced Neoplasia in Pancreatic Cysts". Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
What is the current status of trial NCT03855800?
This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2018-05-11. Estimated completion is 2030-12-30.
What conditions does trial NCT03855800 study?
This clinical trial studies the following conditions: Pancreas Cyst.
What interventions are being tested in trial NCT03855800?
The interventions under investigation include: Blood, stool, pancreatic juice and cyst fluid collection (DIAGNOSTIC_TEST), Pancreatic Surgery (PROCEDURE), Endoscopy Exam (PROCEDURE).
Who is sponsoring clinical trial NCT03855800?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03855800 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreas Cyst
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI